The Plug Medical Group

The Plug Medical Group (TPMG) is a UK specialist pain clinic providing patients with access to medical cannabis prescriptions. Based on Harley Street in London and founded in 2023, the clinic focuses on people living with chronic pain, epilepsy and a range of other health conditions who are seeking alternative solutions when standard treatments have not been sufficient. It positions medicinal cannabis as a way to help relieve chronic pain and improve quality of life, used alongside existing therapies rather than as a replacement.

Service

TPMG specialises in advanced medical cannabis therapies for chronic pain relief. The clinic provides access to specialist doctors through a nationwide telemedicine service, with in person appointments available in London. Patients who register interest are assessed for eligibility, and those approved are offered personalised medicinal cannabis treatment, using scientifically selected formulations aimed at optimising symptom management. Medication is prescribed and supplied via UK partners who cultivate medical cannabis in an indoor facility under Good Manufacturing Practice conditions, with TPMG guaranteeing availability of the products they prescribe.

Safety

TPMG describes its care as closely supervised, with doctors monitoring treatment to support patient wellbeing and safety. All patients follow a structured consent and dosing process: medicinal cannabis is started at a low dose and increased stepwise only if no adverse events occur, in line with recognised advice that slow titration reduces side effect risk. The clinic publishes detailed information on potential side effects (for example difficulty concentrating, drowsiness, anxiety and, rarely, psychosis with THC only formulations) and acknowledges that medical cannabis can be addictive in susceptible individuals, outlining measures to minimise addictive behaviour such as low starting doses, balanced THC and CBD products and quantity limits. Data handling, privacy, and consent to treatment are covered in formal consent documents and policies, including information on who may access medical data and how anonymised data may be used for clinical oversight and service evaluation.

Care pathway

Becoming a patient starts with providing medical information via the “Become a Patient” process. Prospective patients upload photographic ID and a GP summary of their medical record so that the clinic can review their case. This information is then assessed at a Multi Disciplinary Team meeting made up of healthcare professionals from different specialties, who decide whether medicinal cannabis treatment is appropriate. If the MDT agrees, the patient is invited to book an initial video consultation with a specialist doctor. During this consultation, the doctor confirms eligibility, discusses risks and benefits, witnesses electronic signing of the consent form and, if both agree to proceed, issues a prescription that is sent to a pharmacy, which then arranges home delivery of the medicine. Ongoing care includes quarterly review appointments by video with the doctor to discuss effectiveness and adjust dosing when needed, with additional consultations available earlier if the patient or nurse team identifies a need for change.

This description was generated based on information from the official website and other materials provided by the provider.